Jupiter Neurosciences
$3.28
14
+$0.02+0.61% Friday 20:00
+$0.00+0%Friday 23:10After hours
Statistics
Day High
3.34
Day Low
3.34
52W High
135
52W Low
3.26
Volume
300
Avg. Volume
-
Mkt Cap
4.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-3.75
-2.51
-1.26
-0.02
Expected EPS
-3.75
Actual EPS
N/A
Financials
-39,295.45%Profit Margin
Unprofitable22,000Revenue
-8.65MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JUNS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
Show more...
CEO
Christer Rosen
Employees
5
Country
United States
ISIN
US48208B3024
Listings
0 Comments
Share your thoughts
FAQ
What is Jupiter Neurosciences stock price today?▼
The current price of JUNS is $3.28 USD — it has increased by +0.61% in the past 24 hours. Watch Jupiter Neurosciences stock price performance more closely on the chart.
What is Jupiter Neurosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Jupiter Neurosciences stocks are traded under the ticker JUNS.
Is Jupiter Neurosciences stock price growing?▼
JUNS stock has fallen by -21.53% compared to the previous week, the month change is a -43.2% fall, over the last year Jupiter Neurosciences has showed a -96.44% decrease.
What is Jupiter Neurosciences market cap?▼
Today Jupiter Neurosciences has the market capitalization of 4.32M
When is the next Jupiter Neurosciences earnings date?▼
Jupiter Neurosciences is going to release the next earnings report on December 02, 2026.
What is Jupiter Neurosciences revenue for the last year?▼
Jupiter Neurosciences revenue for the last year amounts to 22,000 USD.
What is Jupiter Neurosciences net income for the last year?▼
JUNS net income for the last year is -8.65M USD.
How many employees does Jupiter Neurosciences have?▼
As of September 05, 2026, the company has 5 employees.
In which sector is Jupiter Neurosciences located?▼
Jupiter Neurosciences operates in the Health & Wellness sector.
When did Jupiter Neurosciences complete a stock split?▼
The last stock split for Jupiter Neurosciences was on August 07, 2026 with a ratio of 1:75.
Where is Jupiter Neurosciences headquartered?▼
Jupiter Neurosciences is headquartered in JUPITER, United States.